Cannabidiol (CBD), as a major phytocannabinoid of Cannabis sativa, has emerged as a
promising natural compound in the treatment of diseases. Its diverse pharmacological …

Cannabidiol (CBD), derived from Cannabis sativa, has gained remarkable attention for its
potential therapeutic applications. This thorough analysis explores the increasing …

Background Evidence suggests cannabidiol (CBD) has anxiolytic properties, indicating
potential for novel treatment strategies. However, few clinical trials of CBD-based products …

Psychiatric disorders associated with psychological trauma, stress and anxiety are a highly
prevalent and increasing cause of morbidity worldwide. Current therapeutic approaches …

Background Cannabidiol (CBD) is one of the main phytocannabinoids found in Cannabis
sativa. In contrast to Δ9-tetrahydrocannabinol, it has a low affinity for cannabinoid receptors …

Rationale: Cannabidiol (CBD), the major non-psychoactive constituent of cannabis, has
therapeutic potential for the treatment of anxiety. Most preclinical studies investigate only …

Growing evidence from male rodent and human studies suggests that cannabidiol (CBD)
modulates the expression of aversive memories and anxiety-related responses. The limited …

Objective Autism spectrum disorder (ASD) is characterized by persistent deficits in social
communication and social interaction and by restricted and repetitive patterns of behavior …

Binge alcohol consumption among adolescents affects the developing neural networks
underpinning reward and stress processing in the nucleus accumbens (NAc). This study …

Introduction Varying public views on cannabis use across countries may explain the
variation in the prevalence of use, policies, and research in individual countries, and global …